Skip to main content

Table 1 Patent characteristics

From: Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial

Characteristics

Arm A

(n = 38)

Arm B

(n = 40)

p

Male:female, n (%)

26 (68): 12 (32)

25 (63): 15 (37)

0.58

Mean (SD) age, years

62

(6)

63

(9)

0.39

Mean (SD) BSA, m2

1.59

(0.15)

1.61

(0.18)

0.72

PS, n (%)

 0

36

(95)

37

(92)

1.00

 1

2

(5)

3

(8)

 

Histology, n (%)

 Adenocarcinoma

26

(68)

24

(60)

0.70

 Squamous cell ca.

10

(26)

13

(32)

 

 Large cell carcinoma

2

(5)

2

(5)

 

 Adenosquamous ca.

0

(0)

1

(3)

 

Stage, n (%)

 IB

28

(74)

33

(82)

0.39

 IIA

2

(5)

0

(0)

 

 IIB

5

(13)

3

(8)

 

 IIIA

3

(8)

4

(10)

 

Surgical procedure, n (%)

 Lobectomy

38

(100)

37

(92)

0.40

 Bilobectomy

0

(0)

1

(3)

 

 Pneumonectomy

0

(0)

1

(3)

 

 Segmentectomy

0

(0)

1

(3)

 
  1. BSA body surface area, PS performance status, squamous cell ca. squamous cell carcinoma, adenosquamous ca. adenosquamous carcinoma; p values for sex, PS, type of histology, pathological stage, and surgical procedure were calculated with the use of the chi-square test. p values for age and BSA were calculated with the use of the Student t-test